Compare

Imperial Brands/£IMB

1D1W1M3M6MYTD1Y5YMAX

About Imperial Brands

Imperial Brands PLC is a multinational tobacco company based in Bristol, United Kingdom. It operates in the tobacco industry, manufacturing and distributing a wide range of tobacco and nicotine products. Its core segments include cigarettes, fine-cut tobacco, cigars, and the growing next-generation products category, which encompasses e-cigarettes and heated tobacco products. Founded in 1901 as the Imperial Tobacco Company, it has evolved through various mergers and acquisitions to become a prominent global player. The company operates in several regions worldwide, with a significant presence in Europe, the Americas, and Asia. Imperial Brands focuses on leveraging its portfolio of well-known brands, operational efficiencies, and strategic investments in reduced-risk products to maintain its market position.
Ticker
£IMB
Primary listing
LSE
Employees
25,100

Imperial Brands Metrics

BasicAdvanced
£22B
13.74
£2.15
0.15
£1.64
5.55%

What the Analysts think about Imperial Brands

Analyst ratings (Buy, Hold, Sell) for Imperial Brands stock.
Analyst projections of the future price of Imperial Brands stock.

Bulls say / Bears say

Imperial expects tobacco revenue to grow for a sixth year, as pricing and share gains in the US and Germany offset low-single-digit volume declines. That suggests the core business still has pricing power. (Reuters)
Next-generation products are growing faster than cigarettes: Imperial expects double-digit revenue growth and says it is gaining share across heated tobacco, vaping and modern oral products. This gives the group a growing business beyond combustibles. (Reuters)
The company expects more than £2.2 billion of free cash flow and high-single-digit adjusted EPS growth, and has announced a further £1.5 billion buyback for FY27. That supports substantial shareholder returns if its forecasts hold. (Reuters)
Cigarette volumes are still falling, while Imperial's aggregate market share across its five largest markets was 16 basis points lower year on year at the half-year. Continued share loss could make it harder for pricing to offset shrinking sales. (Imperial Brands)
The half-year figures show how legal and restructuring costs can weigh on reported results: a £313 million settlement charge and £210 million of strategy costs contributed to a 38.1% fall in reported EPS. These costs make headline earnings more volatile than adjusted results suggest. (Investor Meet Company)
Competition could weaken Imperial's growth: UBS cited price investment by Altria and nicotine-pouch competition from BAT, and expected slower NGP revenue growth than consensus. It also saw limited scope for a further valuation re-rating. (LSE.co.uk)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2026.

Imperial Brands Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Imperial Brands Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Imperial Brands

AllEURGBPUSD
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.